← Back to guidelines
Oncology13 papers

Adenomatous polyposis coli

Last edited: 4/15/2026

Overview

Adenomatous polyposis coli (APC) syndromes, including familial adenomatous polyposis (FAP) and other rare forms like MUTYH-associated polyposis (MAP) and gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS), are hereditary conditions characterized by an increased risk of colorectal and other cancers due to mutations in the APC gene 1.

Diagnosis

  • Genetic Testing: Identification of APC gene mutations is crucial for diagnosis 1.
  • Colonoscopy: Regular colonoscopies to detect numerous polyps, typically hundreds to thousands, are essential 1.
  • Exon Analysis: Specific exon analysis can help identify different isoforms and mutations affecting APC function 3.
  • Management

  • Surgical Intervention: Total colectomy is recommended to prevent colorectal cancer development 1.
  • Surveillance: Frequent endoscopic surveillance to monitor polyp burden and early detection of adenomas 1.
  • Chemoprevention: Use of nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce polyp formation, though specific dosing is not detailed in the abstracts 1.
  • Special Populations

  • Pregnancy: Management strategies should consider the impact on maternal and fetal health; tailored surveillance protocols are advised 1.
  • Pediatrics: Early genetic counseling and surveillance initiation post-diagnosis to monitor polyp development 1.
  • Elderly: Tailored surveillance based on life expectancy and overall health status, balancing risks and benefits 1.
  • Key Recommendations

  • Genetic Testing and Counseling: Essential for diagnosis and family screening (Evidence: Strong 1).
  • Regular Colonoscopy Surveillance: Initiate early and maintain frequent intervals to monitor polyp burden (Evidence: Strong 1).
  • Total Colectomy: Recommended to mitigate colorectal cancer risk (Evidence: Strong 1).
  • References

    1 Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, Maffioli A, Bisseling T et al.. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision. The British journal of surgery 2024. link 2 Nathke I. Inke Nathke: The ABCs of APC. Interview by Caitlin Sedwick. The Journal of cell biology 2010. link 3 Kraus C, Reina-Sanchez J, Suleková Z, Ballhausen WG. Immunochemical identification of novel high-molecular-weight protein isoforms of the adenomatous polyposis coli (APC) gene. International journal of cancer 1996. link1097-0215(19960126)65:3<383::AID-IJC18>3.0.CO;2-B)

    Original source

    1. [1]
    2. [2]
      Inke Nathke: The ABCs of APC. Interview by Caitlin Sedwick.Nathke I The Journal of cell biology (2010)
    3. [3]
      Immunochemical identification of novel high-molecular-weight protein isoforms of the adenomatous polyposis coli (APC) gene.Kraus C, Reina-Sanchez J, Suleková Z, Ballhausen WG International journal of cancer (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG